Literature DB >> 12618539

QTc prolongation and high-dose olanzapine.

Sean Dineen, Kirk Withrow, Liouda Voronovitch, Firoz Munshi, Mohammad Wally Nawbary, Steven Lippmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12618539     DOI： 10.1176/appi.psy.44.2.174

Source DB:  PubMed          Journal:  Psychosomatics        ISSN： 0033-3182            Impact factor:   2.386


× No keyword cloud information.
  4 in total

Review 1.  The QT interval and psychotropic medications in children: recommendations for clinicians.

Authors:  Paul McNally; Fiona McNicholas; Paul Oslizlok
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-29       Impact factor: 4.785

Review 2.  First-episode schizophrenia: a focus on pharmacological treatment and safety considerations.

Authors:  Deanna L Kelly; Robert R Conley; William T Carpenter
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Complete atrioventricular block-induced Torsade de pointes, manifested by epilepsy.

Authors:  Jun Han Jeon; Sung Ho Her; Jung Yeon Chin; Ki Hoon Park; Hee Jeong Yoon; Jong Min Lee; Seung Won Jin
Journal:  Korean J Intern Med       Date:  2011-03-02       Impact factor: 2.884

Review 4.  QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.

Authors:  Mehrul Hasnain; W Victor R Vieweg
Journal:  CNS Drugs       Date:  2014-10       Impact factor: 5.749
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.